
IsoPlexis Investor Relations Material
Latest events

Status Update
IsoPlexis
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from IsoPlexis Corporation
Access all reports
IsoPlexis Corporation is a life sciences company that develops single-cell analysis solutions to advance precision medicine and immunology research. The company’s technology platform allows researchers to analyze the functional proteomics of individual cells, providing insights into immune system responses and disease progression. The company is headquartered in Branford, Connecticut, and its shares are listed on the NASDAQ.
Latest articles
)
The Fifteenth Generation: A Conversation with Pietro Gussalli Beretta
An interview with Pietro Gussalli Beretta on how Beretta Holding blends 500 years of tradition with global growth, innovation, and long-term vision.
10 Jul 2025
)
Citadel: Relentless Optimization at Global Scale
From a Harvard dorm to global dominance, this is the story of how Ken Griffin created one of the best-performing hedge funds of all time.
4 Jul 2025
)
David A. Ricks: Eli Lilly's Chairman and CEO
David Ricks built a decades-long career at Eli Lilly, now leading the giant company through a defining moment in its long pharmaceutical history.
3 Jul 2025
Ticker symbol
ISO
Country
🇺🇸 United States